Switch to:
More From Other Websites
Loving 'unloved' stocks: Pro May 23 2016
Horizon (HZNP) to Buy Global Rights to Actimmune, Stock Down May 20 2016
Horizon Pharma plc to Acquire Worldwide Rights to Interferon Gamma-1b From Boehringer Ingelheim... May 19 2016
HORIZON PHARMA PLC Files SEC form 8-K, Other Events, Financial Statements and Exhibits May 19 2016
Horizon Pharma plc to Acquire Worldwide Rights to Interferon Gamma-1b From Boehringer Ingelheim... May 19 2016
Horizon Pharma plc to Participate in UBS Global Healthcare Conference May 18 2016
Horizon Pharma plc to Participate in UBS Global Healthcare Conference May 18 2016
HORIZON PHARMA PLC Financials May 18 2016
ETF’s with exposure to Horizon Pharma Plc : May 16, 2016 May 16 2016
Horizon Pharma Plc :HZNP-US: Earnings Analysis: Q1, 2016 By the Numbers May 12 2016
Bulls bet on rebound in Horizon Pharma May 12 2016
A Move Lower Is on the Horizon (Pharma) May 12 2016
Horizon Pharma plc Announces That Marilyn Vetter Honored as a 2016 Healthcare Businesswomen's... May 12 2016
Horizon Pharma plc Announces That Marilyn Vetter Honored as a 2016 Healthcare Businesswomen's... May 12 2016
Horizon Pharma plc Announces Settlement of PENNSAID(R) (diclofenac sodium topical solution) 2% w/w... May 12 2016
Horizon Pharma plc Announces Settlement of PENNSAID(R) (diclofenac sodium topical solution) 2% w/w... May 12 2016
Nuvo Pharmaceuticals™ Announces 2016 First Quarter Results May 11 2016
IBB Mid-Cap Stocks: Horizon Pharma Soars on Better Earnings May 11 2016
Horizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of Additional Notice of... May 11 2016
Horizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of Additional Notice of... May 11 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK